THIRD-PARTY MANUFACTURING COMPANY IN INDIA- DOYO
Third-Party Manufacturing Company in India– DOYO
A third-party manufacturing company in India – DOYO, the leading third-party pharma manufacturing company – is ISO certified and has 25+ different products.
Segment manufacturing while all manufacturing plants are WHO and GMP certified. Becoming a certified third-party manufacturing company in India. We have one-
stop solutions that include leadership and consultation on pharma marketing, unique and innovative packaging, and packaging content concepts to meet all needs. We provide clinical trials and lab tastes as well as quality assurance for the entire product.
DOYO is a leading third-party manufacturing company in India offering tablets, capsules, powders, injectors, and oral solutions such as high-shear granulation, B-layers, liquid-bed processing, and film coatings. If you are looking for manufacturers who are involved in integrated manufacturing then join us. We are also developing products on customization.
Strenuously Growth of the Pharmaceutical Industry:-
The pharmaceutical industry is growing at a growth rate of over 20% CAGR. The fast-growing Indian pharmaceutical industry is also giving a boost to the Indian economy. Not only that, but India is the largest manufacturer of generic drugs and exports them to different parts of the world. With this rapid growth rate, it is believed that India will soon be in the top 10 in global markets. Join a versatile third-party pharma manufacturing company to start your franchise company.
Quality Pharmaceutical Products List
DOYO has always dedicated itself to bringing better quality drugs. We deal in over 300+ drug formulations to cater to different markets and therapeutic segments of the pharmaceutical industry. We are constantly in touch with the growing demand of consumers. Known for our patient-centered approach, we have ensured that our partners will enjoy quality, sustainable, effective, reliable, and secure solutions. They approve DCGI with FSSAI certification. Our products include pharma tablets, capsules, soft gels, injectable, powders, sachets, etc. These include the following categories:
• Anti-Alcoholism
• Anti-Allergic
• Anti-Arthritic
• Antibiotics
• Anticonvulsants
• Antidepressants
• Antidiabetics
• Antiemetics & Vertigo
• Anti-Inflammatory
• Antimigraine
• Antiparkinsonian
• Antiplatelets
• Antipsychotics
• Antiulcer Hyperacidity
• Anxiolytics
• Cerebral Activators
• Dermatological
• NSAID’s
• OTC Products
• Supportive medication for COVID-19/Coronavirus
• Vitamins & Minerals etc.
Thermometer
Thermometers are an important tool to measure the temperature of a person. Accurate reading of a person’s temperature is important in fever management. There are different types of thermometers and how to use them, but it’s time to call your healthcare provider for more information about your health.
Having a reliable medical thermometer at home can be very helpful to your healthcare management. The ability to accurately inform if someone has a fever gives you much-needed information about the next steps needed to care for them
Best third-party pharmaceutical companies in Baddi
best third-party pharmaceutical companies in Baddi. Are you looking for the top leading third party manufacturing units in Baddi, Himachal Pradesh, India? At this point, yes, you can’t be higher than that. Baddi is undoubtedly the center of practice for all kinds of industries and pharmaceutical techniques. There is no exception. It is very difficult to choose a single organization in such a significant number. With these lines, we’ve added a rundown of the best third-party contract manufacturers in Baddi.
DOYO
DOYO stands out as one of the best pharmacy companies not only for its amazing healthcare but also delivering reliable pharmaceutical, nutritional products and medical equipment.
Contact For Query
doyoseo@gmail.com
9814135709
SCF 135, 2nd Floor, Urban Estate
Sector 17, Panchkula, Haryana, Pin Code: 134113
- Monday
- 10:00 am – 6:30 pm
- Tuesday
- 10:00 am – 6:30 pm
- Wednesday
- 10:00 am – 6:30 pm
- Thursday
- 10:00 am – 6:30 pm
- Friday
- 10:00 am – 6:30 pm
- Saturday
- 10:00 am – 6:30 pm
- Sunday
- Closed
S.No | Generic Name | COMPOSITION | ||||
| 1 | Aceclofenac & Paracetamol Tablets | Each Film Coated Tablet Contains : Aceclofenac IP 100 mg & Paracetamol IP 325 mg | ||||
| 2 | Aceclofenac & Thiocolchicoside Tablets | Each Film Coated Tablet Contains: Aceclofenac IP 100 mg & Thiocolchicosidel IP 8 mg | ||||
| 3 | Aceclofenac & Thiocolchicoside Tablets | Each Film Coated Tablet Contains: Aceclofenac IP 100 mg & Thiocolchicosidel IP 4 mg | ||||
| 4 | Diclofenac Potassium & Serrationpeptidase Tablets | Each Film Coated Tablet Contains: Diclofenac Potassium BP 50 mg & Serratiopeptidase IP 15 mg (30,000 Units of Serratiopeptidase) (As enteric Coated Granules) Excipients q.s. | ||||
| 5 | Amlodipine & Atenolol Tablets | Each Uncoated Tablet Contains : Amlodipine Besylate IP Eq. to Amlodipine 5 mg & Atenolol IP 50 mg Excipients q.s. | ||||
| 6 | Ofloxacin & Ornidazole Tablets | Each Film Coated Tablet Contains: Ofloxacin IP 200 mg & Ornidazole IP 500 mg Excipients q.s. | ||||
| 7 | Propranolol Tablets IP | Each Uncoated Tablet Contains : Propranolol Hydrochloride IP 20 mg Excipients q.s. | ||||
| 8 | Isoxsuprine Hydrochloride Sustained Release Tablets | Each Uncoated Sustained Release Tablet Contains : Isoxsuprine Hydrochloride IP 40 mg Excipients q.s. | ||||
| 9 | Terbinafine Tablets USP | Each Film coated Tablet Contains : Terbinafine Hydrochloride BP Eq. To Terbinafine 250 mg Excipients q.s. | ||||
| 10 | Losartan Potassium Tablets IP | Each Film coated Tablet Contains : Losartan Potassium IP 50 mg Excipients q.s. | ||||
| 11 | Losartan Potassium & Hydrochlorothiazide Tablets IP | Each Film coated Tablet Contains : Losartan Potassium IP 50 mg & Hydrochlorothiazide IP 12.5 mg Excipients q.s. | ||||
| 12 | Telmisartan Tablets IP | Each Film coated Tablet Contains : Telmisartan IP 40 mg Excipients q.s. | ||||
| 13 | Telmisartan & Amlodipine Tablets IP | Each Film coated Tablet Contains : Telmisartan IP 40 mg & Amlodipine Besylate IP Eq. to Amlodipine 5 mg Excipients q.s. | ||||
| 14 | Tamsulosin Hydrochloride (Modified Release) & Dutasteride Tablets | Each Film coated Tablet Contains : Tamsulosin Hydrochloride IP 0.4 mg &(As Modified Release) & Dutasteride IP 0.5 mg | ||||
| 15 | Betacyclodextrin & Piroxicam Tablets | Each Uncoated Tablet Contains : Betacyclodextrin IP 100 mg & Piroxicam IP 20 mg Excipients q.s. | ||||
| 16 | Deflazacort 30 mg. Tablets | Each Uncoated Tablet Contains : Deflazacort IP 30 mg. Excipients | ||||
| 17 | Drotaverine Hydrochloride Tablets IP | Each Uncoated Tablet Contains : Drotaverine Hydrochloride IP &(Dihydro Ethaverine Chloride) 80 mg Excipients q.s. | ||||
| 18 | Etamsylate Tablets BP | Each Film Coated Tablet Contains : Etamsylate BP 500 mg Excipients q.s. | ||||
| 19 | Etamsylate & Tranexamic Acid Tablets | Each Film Coated Tablet Contains : Etamsylate BP 250 mg & Tranexamic Acid IP 250 mg Excipients q.s. | ||||
| 20 | Tranexamic Acid & Mefenamic Acid Tablets | Each Uncoated Tablet Contains : Tranexamic Acid IP 500 mg & Mefenamic Acid IP 250 mg Excipients q.s. | ||||
| 21 | Linezolid Tablets IP | Each Film Coated Contains : Linezolid IP 600 mg | ||||
| 22 | Acyclovir Tablets IP | Each Uncoated Tablet Contains : Acyclovir IP 200 mg | ||||
| 23 | Acyclovir Tablets IP | Each Uncoated Tablet Contains : Acyclovir IP 400 mg | ||||
| 24 | Acyclovir Tablets IP | Each Uncoated Tablet Contains : Acyclovir IP 800 mg | ||||
| 25 | Allopurinol Tablets IP | Each Uncoated Tablet Contains :Allopurinol IP 100 mg | ||||
| 26 | Esomeprazole Tablets IP | Each Enteric Coated Tablet Contains : Esomeprazole Magnesium & Trihydrate IP Eq. to Esomeprazole 40 mg | ||||
| 27 | Faropenem Tablets | Each Film Coated Tablet Contains : Faropenem Sodium Eq. To Faropenem 200 mg | ||||
| 28 | Atorvastatin Tablets IP | Each Film Coated Tablet Contains : Atorvastatin Calcium IP Eq. To Atorvastatin 10 mg | ||||
| 29 | Atorvastatin Tablets IP | Each Film Coated Tablet Contains : Atorvastatin Calcium IP Eq. To Atorvastatin 20 mg | ||||
| 30 | Artemether & Lumefantrine Dispersible Tablets | Each Uncoated Dispersible Tablet Contains : Artemether IP 20 mg & Lumefantrine USP 120 mg | ||||
| 31 | Artemether & Lumefantrine Tablets | Each Uncoated Tablet Contains : Artemether IP 80 mg & Lumefantrine USP 480 mg | ||||
| 32 | Glimepiride & Metformin Hydrochloride (Sustained Release) Tablets | Each Uncoated Bilayered Tablet Contains : Glimepiride IP 1 mg & Metformin Hydrochloride IP 500 mg ( As Sustained Release) | ||||
| 33 | Glimepiride & Metformin Hydrochloride (Sustained Release) Tablets | Each Uncoated Bilayered Tablet Contains : Glimepiride IP 2 mg & Metformin Hydrochloride IP 500 mg ( As Sustained Release) | ||||
| 34 | Glimepiride & Metformin Hydrochloride (Sustained Release) Tablets | Each Uncoated Bilayered Tablet Contains : Glimepiride IP 1 mg & Metformin Hydrochloride IP 1000 mg ( As Sustained Release) | ||||
| 35 | Glimepiride & Metformin Hydrochloride (Sustained Release) Tablets | Each Uncoated Bilayered Tablet Contains : Glimepiride IP 2 mg & Metformin Hydrochloride IP 1000 mg ( As Sustained Release) | ||||
| 36 | Glimepiride & Metformin Hydrochloride (Sustained Release) & Pioglitazone Tablets | Each Uncoated Bilayered Tablet Contains : Glimepiride IP 1 mg & Metformin Hydrochloride IP 500 mg ( As Sustained Release) & Pioglitazone Hydrochloride IP Eq. to Pioglitazone 15 mg | ||||
| 37 | Glimepiride & Metformin Hydrochloride (Sustained Release) & Pioglitazone Tablets | Each Uncoated Bilayered Tablet Contains : Glimepiride IP 2 mg & Metformin Hydrochloride IP 500 mg ( As Sustained Release) & Pioglitazone Hydrochloride IP Eq. to Pioglitazone 15 mg | ||||
| 38 | Sitagliptin Tablets IP | Each Film Coated Tablet Contains : Sitagliptin Phosphate Monohydrate IP Eq. to Sitagliptin 100 mg. | ||||
| 39 | Sitagliptin & Metformin Hydrochloride Tablets | Each Film Coated Tablet Contains : Sitagliptin Phosphate Monohydrate IP Eq. to Sitagliptin 50 mg & Metformin Hydrochloride IP 500 mg. | ||||
| 40 | Albendazole Tablets IP | Each Uncoated Chewable Tablet Contains : Albendazole IP 400 mg. | ||||
| 41 | Thiocolchicoside Tablets | Each Film Coated Tablet Contains : Thiocolchicoside IP 4 mg. | ||||
| 42 | Tapentadol Tablets | Each Film Coated Tablet Contains : Tapentadol Hydrochloride IP Eq. to Tapentadol 50 mg. | ||||
| 43 | Tapentadol Tablets | Each Film Coated Tablet Contains : Tapentadol Hydrochloride IP Eq. to Tapentadol 100 mg. | ||||
| 44 | Acebrophylline Sustained Release Tablets | Each Uncoated Sustained Release Tablet Contains : Acebrophylline 200 mg. | ||||
| 45 | Azathioprine Tablets IP | Each Uncoated Tablet Contains : Azathioprine IP 50 mg. | ||||
| 46 | Ketorolac Tromethamine Tablets IP | Each Film Coated Tablet Contains : Ketorolac Tromethamine IP 10 mg. | ||||
| 47 | Azithromycin Tablets IP | Each Film Coated Tablet Contains : Azithromycin (Dihydrate) IP Eq. to Azithromycin (Anhydroud) 250 mg. | ||||
| 48 | Azithromycin Tablets IP | Each Film Coated Tablet Contains : Azithromycin (Dihydrate) IP Eq. to Azithromycin (Anhydroud) 500 mg. | ||||
| 49 | Ofloxacin Tablets IP | Each Film Coated Tablet Contains : Ofloxacin IP 200 mg. | ||||
| 50 | Levofloxacin Tablets IP | Each Film Coated Tablet Contains : Levofloxacin Hemihydrate IP Eq. to Levofloxacin 250 mg. | ||||
| 51 | Levofloxacin Tablets IP | Each Film Coated Tablet Contains : Levofloxacin Hemihydrate IP Eq. to Levofloxacin 500 mg. | ||||
| 52 | Levofloxacin Tablets IP | Each Film Coated Tablet Contains : Levofloxacin Hemihydrate IP Eq. to Levofloxacin 750 mg. | ||||
| 53 | Sparfloxacin Tablets | Each Film Coated Tablet Contains : Sparfloxacin 200 mg. | ||||
| 54 | Ciprofloxacin Tablets IP | Each Film Coated Tablet Contains : Ciprofloxacin Hydrochloride IP Eq. to Ciprofloxacin 500 mg. | ||||
| 55 | Clarithromycin Tablets IP | Each Film Coated Tablet Contains : Clarithromycin IP 250 mg. | ||||
| 56 | Clarithromycin Tablets IP | Each Film Coated Tablet Contains : Clarithromycin IP 500 mg. | ||||
| 57 | Serratiopeptidase Tablets IP | Each Film Coated Tablet Contains : Serratiopeptidase IP 10 mg (20,000 Units Of Serratiopeptidase ) (As Enteric Coated Granules) | ||||
| 58 | Doxofylline Tablets IP | Each Uncoated Tablet Contains : Doxofylline IP 400 mg. | ||||
| 59 | Ferrous Ascorbate, Folic Acid & Zinc Sulphate Tablets | Each Film Coated Tablet Contains : Ferrous Ascorbate 100 mg & Folic Acid IP 1.5 mg & Zinc Sulphate Monohydrate IP 61.8 mg Eq. to Elemental Zinc 22.5 mg. | ||||
| 60 | Methylcobalamin Tablets JP | Each Film Coated Tablet Contains : Methylcobalamin IP 500 mcg. | ||||
| 61 | Ferrous Ascorbate, Folic Acid, Zinc & Adenosylcobalamin Tablets | Each Film Coated Tablet Contains : Ferrous Ascorbate Eq. to Elemental Iron 100 mg & Folic Acid IP 1.5 mg & Zinc Sulphate Monohydrate IP 61.8 mg & Eq. to Elemental Zinc 22.5 mg & Adenosylcobalamin IP 15 mcg. | ||||
| 62 | Methylcobalamin & Gabapentin Tablets | Each Film Coated Tablet Contains : Methylcobalamin IP 500 mcg & Gabapentin IP 300 mg. | ||||
| 63 | Methylcobalamin & Pregabalin (Sustained Release) Tablets | Each Film Coated Tablet Contains : Methylcobalamin IP 1500 mcg & Pregabalin IP 75 mg (As Sustained Release Form) | ||||
| 64 | Methylcobalamin & Pregabalin (Sustained Release) Tablets | Each Film Coated Tablet Contains : Methylcobalamin IP 1500 mcg & Pregabalin IP 150 mg (As Sustained Release Form) | ||||
| 65 | Aceclofenac & Paracetamol Tablets | Each Film Coated Tablet Contains : Aceclofenac IP 100 mg & Paracetamol IP 325 mg. | ||||
| 66 | Aceclofenac Tablets | Each Uncoated Tablet Contains : Aceclofenac IP 100 mg. | ||||
| 67 | Aceclofenac Sustained Release Tablets | Each Uncoated Sustained Release Tablet Contains : Aceclofenac IP 200 mg. | ||||
| 68 | Aceclofenac & Diacerin Tablets | Each Film Coated Tablet Contains : Aceclofenac IP 100 mg & Diacerin IP 50 mg. | ||||
| 69 | Aceclofenac & Drotaverine Hydrochloride Tablets | Each Film Coated Tablet Contains : Aceclofenac IP 100 mg &Drotaverine Hydrochloride IP 80 mg(Dihydro Ethaverine Chloride) | ||||
| 70 | Diclofenac Sodium & Tolperisone Hydrochloride Tablets | Each Film Coated Tablet Contains : Diclofenac Sodium IP 50 mg & Tolperisone Hydrochloride IP 150 mg. | ||||
| 71 | Lornoxicam & Paracetamol Tablets | Each Uncoated Tablet Contains : Lornoxicam 4 mg & Paracetamol IP 325 mg. | ||||
| 72 | Lornoxicam & Paracetamol Tablets | Each Uncoated Tablet Contains : Lornoxicam 8 mg & Paracetamol IP 325 mg. | ||||
| 73 | Etoricoxib Tablets IP | Each Film Coated Tablet Contains : Etoricoxib IP 60 mg. | ||||
| 74 | Etoricoxib Tablets IP | Each Film Coated Tablet Contains : Etoricoxib IP 90 mg. | ||||
| 75 | Etoricoxib Tablets IP | Each Film Coated Tablet Contains : Etoricoxib IP 120 mg. | ||||
| 76 | Etoricoxib & Acetaminophen Tablets | Each Film Coated Tablet Contains : Etoricoxib IP 60 mg & Acetaminophen IP 325 mg. | ||||
| 77 | Etoricoxib & Thiocolchicoside Tablets | Each Film Coated Tablet Contains : Etoricoxib IP 60 mg & Thiocolchicoside IP 4 mg. | ||||
| 78 | Etoricoxib & Thiocolchicoside Tablets | Each Film Coated Tablet Contains : Etoricoxib IP 60 mg & Thiocolchicoside IP 8 mg. | ||||
| 79 | Ornidazole Tablets IP | Each Film Coated Tablet Contains : Ornidazole IP 500 mg. | ||||
| 80 | Ketoconazole Tablets IP | Each Uncoated Tablet Contains : Ketoconazole IP 200 mg. | ||||
| 81 | Fluconazole Tablets IP | Each Uncoated Tablet Contains : Fluconazole IP 100 mg. | ||||
| 82 | Fluconazole Tablets IP | Each Uncoated Tablet Contains : Fluconazole IP 150 mg. | ||||
| 83 | Fluconazole Tablets IP | Each Uncoated Tablet Contains : Fluconazole IP 200 mg. | ||||
| 84 | Levocetirizine Tablets IP | Each Film Coated Tablet Contains : Levocetirizine Hydrochloride IP 10 mg. | ||||
| 85 | Montelukast Sodium & Levocertirizine Hydrochloride Tablets IP | Each Film Coated Tablet Contains : Montelukast Sodium IP Eq. to Montelukast 10 mg & Levocetirizine Hydrochloride IP 5 mg. | ||||
| 86 | Montelukast & Bambuterol Hydrochloride Tablets | Each Uncoated Tablet Contains : Montelukast Sodium IP Eq. to Montelukast 10 mg & Bambuterol Hydrochloride BP 10 mg. | ||||
| 87 | Montelukast & Fexofenadine Hydrochloride Tablets IP | Each Film Coated Tablet Contains : Montelukast Sodium IP Eq. to Montelukast 10 mg & Fexofenadine Hydrochloride IP 120 mg. | ||||
| 88 | Montelukast Sodium Tablets IP | Each Film Coated Tablet Contains : Montelukast Sodium IP Eq. to Montelukast 10 mg. | ||||
| 89 | Fexofenadine Hydrochloride Tablets IP | Each Film Coated Tablet Contains : Fexofenadine Hydrochloride IP 120 mg. | ||||
| 90 | Fexofenadine Hydrochloride Tablets IP | Each Film Coated Tablet Contains : Fexofenadine Hydrochloride IP 180 mg. | ||||
| 91 | Ursodeoxycholic Acid Tablets IP | Each Film Coated Tablet Contains : Ursodeoxycholic Acid IP 300 mg. | ||||
| 92 | Methylprednisolone Tablets IP | Each Uncoated Tablet Contains : Methylprednisolone IP 4 mg. | ||||
| 93 | Methylprednisolone Tablets IP | Each Uncoated Tablet Contains : Methylprednisolone IP 8 mg. | ||||
| 94 | Methylprednisolone Tablets IP | Each Uncoated Tablet Contains : Methylprednisolone IP 16 mg. | ||||
| 95 | Primaquine Tablets IP | Each Film Coated Tablet Contains : Primaquine Phosphate IP Eq. to Primaquine 7.5 mg. | ||||
| 96 | Primaquine Tablets IP | Each Film Coated Tablet Contains : Primaquine Phosphate IP Eq. to Primaquine 15 mg. | ||||
| 97 | Pantoprazole Gastro-Resistant Tablets IP | Each Enteric Coated Tablet Contains : Pantoprazole Sodium Sesquihydrate IP Eq. to Pantoprazole 40 mg. | ||||
| 98 | Rabeprazole Sodium Gastro-Resistant Tablets IP | Each Enteric Coated Tablet Contains : Rabeprazole Sodium IP 20 mg. | ||||
| 99 | Sodium Valproate & Valproic Acid Controlled Release Tablets | Each Film Coated Controlled Release Tablet Contains : Sodium Valproate IP 133 mg & Valproic Acid IP 58 mg(Both together correspond to soduim Valproate 200 mg) | ||||
| 100 | Sodium Valproate & Valproic Acid Controlled Release Tablets | Each Film Coated Controlled Release Tablet Contains : Sodium Valproate IP 200 mg & Valproic Acid IP 87 mg (Both together correspond to soduim Valproate 300 mg) | ||||
| 101 | Sodium Valproate & Valproic Acid Controlled Release Tablets | Each Film Coated Controlled Release Tablet Contains : Sodium Valproate IP 333 mg & Valproic Acid IP 145 mg (Both together correspond to soduim Valproate 500 mg) | ||||
| 102 | Betahistine Hydrochloride Tablets IP | Each Film Coated Tablet Contains : Betahistine Hydrochloride IP 8 mg. | ||||
| 103 | Betahistine Hydrochloride Tablets IP | Each Film Coated Tablet Contains : Betahistine Hydrochloride IP 16 mg. | ||||
| 104 | Citicoline Sodium Tablets IP | Each Film Coated Tablet Contains : Citicoline Sodium IP Eq. to Citicoline 500 mg. | ||||
| 105 | Citicoline & Piracetam Tablets | Each Film Coated Tablet Contains : Citicoline Sodium IP Eq. to Citicoline 500 mg & Piracetam IP 400 mg. | ||||
| 106 | Divalproex Sodium Tablets IP | Each Enteric Coated Tablet Contains : Divalproex Sodium IP Eq. to Valproic Acid 250 mg. | ||||
| 107 | Divalproex Sodium Prolonged Release Tablets IP | Each Film Coated Prolonged Release Tablet Contains : Divalproex Sodium IP Eq. to Valproic Acid 500 mg. | ||||
| 108 | Divalproex Sodium Prolonged Release Tablets IP | Each Film Coated Prolonged Release Tablet Contains : Divalproex Sodium IP Eq. to Valproic Acid 750 mg. | ||||
| 109 | Duloxetine Gasto- Resistant Tablets IP | Each Enteric Coated Tablet Contains : Duloxetine Hydrochloride IP Eq. to Duloxetine 60 mg. | ||||
| 110 | Lamotrigine Dispersible Tablets IP | Each Uncoated Dispersible Tablet Contains : Lamotrigine IP 50 mg. | ||||
| 111 | Etizolam Tablets JP | Each Film Coated Tablet Contains : Etizolam JP 0.5 mg. | ||||
| 112 | Etizolam Tablets JP | Each Film Coated Tablet Contains : Etizolam JP 1 mg. | ||||
| 113 | Iloperidone Tablets IP | Each Film Coated Tablet Contains : Iloperidone IP 4 mg. | ||||
| 114 | Iloperidone Tablets IP | Each Film Coated Tablet Contains : Iioperidone IP 8 mg. | ||||
| 115 | Levetiracetam Tablets USP | Each Film Coated Tablet Contains : Levetiracetam IP 250 mg. | ||||
| 116 | Levetiracetam Prolonged Release Tablets IP | Each Film Coated Prolonged Release Tablet Contains : Levetiracetam IP 500 mg. | ||||
| 117 | Levetiracetam Prolonged Release Tablets IP | Each Film Coated Prolonged Release Tablet Contains : Levetiracetam IP 750 mg. | ||||
| 118 | Naproxen Tablets IP | Each Uncoated Tablet Contains : Naproxen IP 250 mg. | ||||
| 119 | Propranolol Tablets IP | Each Uncoated Tablet Contains : Propranolol Hydrochloride IP 10 mg. | ||||
| 120 | Amlodipine & Analapril Tablets | Each Uncoated Tablet Contains : Amlodipine Besylate IP Eq. to Amlodipine 2.5 mg & Analapril Maleate IP 2.5 mg. Excipients q.s. | ||||
| 121 | Amlodipine & Analapril Tablets | Each Uncoated Tablet Contains : Amlodipine Besylate IP Eq. to Amlodipine 5 mg & Analapril Maleate IP 5 mg. Excipients q.s. | ||||
| 122 | Amlodipine & Atenolol Tablets | Each Uncoated Tablet Contains : Amlodipine Besylate IP Eq. to Amlodipine 5 mg & Atenolol IP 50 mg. Excipients q.s. | ||||
| 123 | Atorvastatin & Ezetimibe Tablets | Each Film Coated Tablet Contains : Atorvastatin Calcium IP Eq. to Atorvastatin 10 mg & Ezetimibe IP 10 mg. Excipients q.s. | ||||
| 124 | Atorvastatin & Ezetimibe Tablets | Each Film Coated Tablet Contains : Atorvastatin Calcium IP Eq. to Atorvastatin 20 mg & Ezetimibe IP 10 mg. Excipients q.s. | ||||
| 125 | Amlodipine & Ramipril Tablets | Each Uncoated Tablet Contains : Amlodipine Besylate IP Eq. to Amlodipine 5 mg & Ramipril IP 2.5 mg. Excipients q.s. | ||||
| 126 | Atorvastatin & Fenofibrate Tablets | Each Film Coated Tablet Contains : Atorvastatin Calcium IP Eq. to Atorvastatin 10 mg & Fenofibrate (Micronised) IP 160 mg. Excipients q.s. | ||||
| 127 | Simvastatin & Ezetimibe Tablets | Each Film Coated Tablet Contains : Simvastatin IP 10 mg & Ezetimibe IP 10 mg. | ||||
| 128 | Simvastatin & Ezetimibe Tablets | Each Film Coated Tablet Contains : Simvastatin IP 20 mg & Ezetimibe IP 10 mg.Excipients q.s. | ||||
| 129 | Telmisartan & Ramipril Tablets | Each Uncoated Tablet Contains : Telmisartan IP 40 mg & Ramipril IP 5 mg. Excipients q.s. | ||||
| 130 | Ramipril & Hydrochlorothiazide Tablets IP | Each Uncoated Tablet Contains : Ramipril IP 2.5 mg & Hydrochlorothiazide IP 12.5 mg. Excipients q.s. | ||||
| 131 | Nimesulide & Levocetirizine Tablets | Each Film Coated Tablet Contains : Nimesulide (As Extended Release) BP 100 mg & Levocetirizine Dihydrochloride IP 5 mg. Excipients q.s. | ||||
| 132 | Artemether & Lumefantrine Tablets | Each Uncoated Tablet Contains : Artemether IP 40 mg & Lumefantrine USP 240 mg. Excipients q.s. | ||||
| 133 | Vildagliptin & Metformin Hydrochloride Tablets | Each Film Coated Tablet Contains : Vildagliptin 50 mg & Metformin Hydrochloride IP 500 mg. Excipients q.s. | ||||
| 134 | Vildagliptin & Metformin Hydrochloride Tablets | Each Film Coated Tablet Contains : Vildagliptin 50 mg & Metformin Hydrochloride IP 850 mg. Excipients q.s. | ||||
| 135 | Vildagliptin & Metformin Hydrochloride Tablets | Each Film Coated Tablet Contains : Vildagliptin 50 mg & Metformin Hydrochloride IP 1000 mg. Excipients q.s. | ||||
| 136 | Aceclofenac & Tizanidine Hydrochloride Tablets | Each Film Coated Tablet Contains : Aceclofenac IP 100 mg & Tizanidine Hydrochloride IP Eq. to Tizanidine IP 2 mg. Excipients q.s. | ||||
| 137 | Ezetimibe & Resuvastatin Tablets IP | Each Film Coated Tablet Contains : Resuvastatin Calcium IP Eq. to Resuvastatin 20 mg & Ezetimibe IP 10 mg. Excipients q.s. | ||||
| 138 | Ezetimibe & Resuvastatin Tablets IP | Each Film Coated Tablet Contains : Resuvastatin Calcium IP Eq. to Resuvastatin 5 mg & Ezetimibe IP 10 mg. Excipients q.s. | ||||
| 139 | Amiloride & Hydrochlorothiazide Tablets IP | Each Uncoated Tablet Contains : Amiloride Hydrochloride IP 2.5 mg(As anhydrous) & Hydrochlorothiazide IP 25 mg. Excipients q.s. | ||||
| 140 | Saxagliptin & Metformin HCL. Exrended Release Tablets | Each Film Coated Tablet Contains : Saxagliptin Hydrochloride Eq. to Saxagliptin 5 mg & Metformin Hydrochloride IP 500 mg (As Extended Release) Excipients q.s. | ||||
| 141 | Montelukast Sodium & Olopatadine Hydrochloride Tablets | Each Film Coated Tablet Contains : Montelukast Sodium IP Eq. to Montelukast 10 mg & Olopatadine Hydrochloride IP 5 mg. Excipients q.s. | ||||
| 142 | Sulfasalazine Delayed – Release Tablets | Each Entric Coated Tablet Contains : Sulfasalazine USP 500 mg. Excipients q.s. | ||||
| 143 | Sulfasalazine Delayed – Release Tablets | Each Entric Coated Tablet Contains : Sulfasalazine USP 1000 mg. Excipients q.s. | ||||
| 144 | Cefixime & Ofloxacin Tablets | Each Film Coated Tablet Contains : Cefixime (as Trihydrate) IP Eq. to Cefixime (Anhydrous) 200 mg & Ofloxacin IP 200 mg. Excipients q.s. | ||||
| 145 | Calcium Carbonate & Vitamin D3 Tablets | Each Film Coated Tablet Contains : Calcium Carbonate (Derived from an organic source oyster shell) IP 1250 mg Eq. to Elemental Calcium 500 mg & Vitamin D3 IP 500 I.U. Excipients q.s. | ||||
| 146 | Ranitidine Hydrochloride Tablets IP | Each Film Coated Tablet Contains : Ranitidine Hydrochloride IP Eq. to Ranitidine 150 mg. Excipients q.s. | ||||
| 147 | Ivermectin & Albendazoile Tablets | Each Uncoated Chewable Tablet Contains : Ivermectin IP 6 mg & Albendazole IP 400 mg. Excipients q.s. | ||||
| 148 | Aceclofenac, Chlorzoxazone & Paracetamol Tablets | Each Film Coated Tablet Contains : Aceclofenac IP 100 mg & Chlorzoxazone USP 250 mg & Paracetamol IP 325 mg. Excipients q.s. | ||||
| 149 | Drotaverine Hydrochloride & Mefenamic Tablets | Each Film Coated Tablet Contains : Mefenamic Acid IP 250 mg & Drotaverine Hydrochloride IP 80 mg. Excipients q.s. | ||||
| 150 | Paracetamol Tablets IP | Each Uncoated Tablet Contains : Paracetamol IP 650 mg. Excipients q.s. | ||||
| 151 | Paracetamol & Aceclofenac Tablets IP | Each Uncoated Tablet Contains : Paracetamol IP 325 mg & Aceclofenac IP 100 mg. Excipients q.s. | ||||
| 152 | Frusemide & Spironolactone Tablets | Each Uncoated Tablet Contains : Frusemid IP 20 mg. Spironolactone IP 50 mg.Excipients q.s. | ||||
| 153 | Aceclofenac, Paracetamol & Serratiopeptidase Tablets | Each Film Coated Tablet Contains : Aceclofenac IP 100 mg & Paracetamol IP 325 mg & Serratiopeptidase IP 15 mg (Eq. to 30,000 units enzyme activities of serratiopeptidase) Excipients q.s. | ||||
| 154 | Chloroquine Phosphate 250 mg Tablet IP | Each Film Coated Tablet Contains : Chloroquine Phosphate IP 250 mg. Equivalent to q.s. Chloroquine Base 155 mg Excipients Colour : Approved Colour Use. | ||||
| 155 | Chloroquine Phosphate 500 mg Tablet IP | Each Film Coated Tablet Contains : Chloroquine Phosphate IP 500 mg. Equivalent to q.s. Chloroquine Base 310 mg Excipients Colour : Approved Colour Use. | ||||
| 156 | Hydroxychloroquine 200 mg Tablet IP | Each Film Coated Tablet Contains : Hydroxychloroquine Sulphate IP 200mg. Excipients q.s. Colour : Approved Colour Use. | ||||
| 157 | Hydroxychloroquine 300 mg Tablet IP | Each Film Coated Tablet Contains : Hydroxychloroquine Sulphate IP 300mg. Excipients q.s. Colour : Approved Colour Use. | ||||
| 158 | Hydroxychloroquine 400 mg Tablet IP | Each Film Coated Tablet Contains : Hydroxychloroquine Sulphate IP 400mg. Excipients q.s. Colour : Approved Colour Use. | ||||
| TABLETS BETA LACTAM | ||||||
| S.NO | PRODUCT NAME | COMPOSITION | ||||
| 1 | Amoxyclav 625mg | Amoxycillin 500 + Clavulanic Acid 125 mg | ||||
| 2 | Amoxyclav 375mg | Amoxycillin 250 + Clavulanic Acid 125 mg | ||||
| 3 | Amoxyclav 428.5 tab | Amoxycillin 200 + Clavulanic Acid 228.5 mg (Kid) | ||||
| 4 | Amoxyclav 625Lb | Amoxycillin 500 + Clavulanic 125 + Lactic Bacillus 60 Million Spores | ||||
| 5 | Amoxyclav 1000mg | Amoxycillin 875 + Clavulanic Acid 125 mg | ||||
| 6 | Cefixime Dispersible Tablets IP | Each Uncoated Dispersible Tablet Contains : Cefixime (As Trihydrate) IP Eq. to Cefixime (Anhydrous) 100 mg. Excipients q.s. | ||||
| 7 | Cefixime 200mg | Cefixime Despersible 200 mg | ||||
| 8 | Cefixime Tablets IP | Each Uncoated Tablet Contains : Cefixime (As Trihydrate) IP Eq. to Cefixime (Anhydrous) 200 mg. Excipients q.s. | ||||
| 9 | Cefixime With Lactic Acid Bacillus Dispersible Tablets | Each Uncoated Dispersible Tablet Contains : Cefixime (As Trihydrate) IP Eq. to Cefixime (Anhydrous) 200 mg & Lactic Acid Bacillus 60 Million Spores | ||||
| 10 | Cefixime+Clav | Cefixime 200 + Clavulanic Acid 125 mg | ||||
| 11 | Cefixime+ofloxacin | Cefixime 200 mg + Ofloxacin 200 mg | ||||
| 12 | Cefpodoxime Dispersible | Cefpodoxime Dispersible 100 mg | ||||
| 13 | Cefpodoxime Tablets IP | Each Uncoated Tablet Contains : Cefpodoxime Proxetil IP Eq. to Cefpodoxime 200 mg. Excipients q.s. | ||||
| 14 | Cefpodoxime+Clav Tablet IP | Each Uncoated Tablet Contains : Cefpodoxime 200 + Clavulanic Acid 125 mg | ||||
| 15 | Cefuroxime Tablets IP | Each Film Coated Tablet Contains : Cefuroxime Axetil IP Eq. to Cefuroxime 250 mg. Excipients q.s. | ||||
| 16 | Cefuroxime Tablets IP | Each Film Coated Tablet Contains : Cefuroxime Axetil IP Eq. to Cefuroxime 500 mg. Excipients q.s. | ||||
| 17 | Cefuroxime Clav 625mg | Cefuroxime 500 + Clavulanic 125 mg | ||||
| 18 | Cefuroxime Clav 375mg | Cefuroxime 250 + Clavulanic 125 mg | ||||
| CAPSULES | ||||||
| S.No | PRODUCT NAME | COMPOSITION | ||||
| 1 | Fluconazole Capsules IP | Each Hard Gelatin Capsule Contains : Fluconazole IP 150 mg | ||||
| 2 | Fluconazole Capsules IP | Each Hard Gelatin Capsule Contains : Fluconazole IP 200 mg | ||||
| 3 | Rabeprazole (EC) & Levosulpiride (SR) Capsules | Each Hard Gelatin Capsule Contains : Rabeprazole Sodium IP 20 mg (As enteric coated pellets) & Levosulpiride IP 75 mg (As sustained release pellets) | ||||
| 4 | Rosuvastatin & Aspirin Capsules | Each Hard Gelatin Capsule Contains : Rosuvastatin Calcium IP Eq. to Rosuvastatin 10 mg(As Granules)& Aspirin IP 75 mg (As enteric coated tablet) | ||||
| 5 | Rosuvastatin & Aspirin Capsules | Each Hard Gelatin Capsule Contains : Rosuvastatin Calcium IP Eq. to Rosuvastatin 10 mg (As Granules)& Aspirin IP 150 mg (As enteric coated tablet) | ||||
| 6 | Atenolol and Nifedipine (SR) Capsules | Each Hard Gelatin Capsule Contains : Atenolol IP 50 mg & Nifedipine IP 20 mg(As sustained Release form) | ||||
| 7 | Esomeprazole (Enteric Coated) and Domperidone (Sustained Release) Capsules | Each Hard Gelatin Capsule Contains : Esomeprazole Magnesium BP Eq. to Esomeprazole 40 mg (As Enteric Coated Pellets)& Domperidone Maleate 30 mg Eq. to Domperidone (As Sustained Release Pellets) | ||||
| 8 | Esomeprazole (Enteric Coated) and Itopride (Sustained Release) Capsules | Each Hard Gelatin Capsule Contains : Esomeprazole Magnesium BP Eq. to Esomeprazole 40 mg (As Enteric Coated Pellets)& Itopride Hydrochloride 150 mg Eq. to Domperidone (As Sustained Release Pellets) | ||||
| 9 | Methylcobalamin,Alpha Lipoic Acid, Thiamine Mononitrate, Pyridoxine Hydrochloride & Folic Acid Capsules | Each Hard Gelatin Capsule Contains : Methylcobalamin IP 1500 mcg & Alpha Lipoic Acid IP 100 mg & Thiamine Mononitrate IP 10 mg& Pyridoxine Hydrochloride IP 3 mg & Folic Acid IP 1.5 mg. | ||||
| 10 | Pregabalin and Methylcobalamin Capsules | Each Hard Gelatin Capsule Contains : Pregabalin IP 75 mg & Methylcobalamin IP 750 mcg. | ||||
| 11 | Pregabalin and Methylcobalamin Capsules | Each Hard Gelatin Capsule Contains : Pregabalin IP 150 mg & Methylcobalamin IP 750 mcg. | ||||
| 12 | Diclofenac (SR) and Thiocolchicoside (SR) Capsules | Each Hard Gelatin Capsule Contains : Diclofenac Sodium IP 100 mg (As Sustained Release Pellets) & Thiocolchicoside IP 16 mg(As Sustained Release Pellets) | ||||
| 13 | Aceclofenac (SR) and Thiocolchicoside (SR) Capsules | Each Hard Gelatin Capsule Contains : Aceclofenac IP 200 mg (As Sustained Release Pellets) & Thiocolchicoside IP 16 mg (As Sustained Release Pellets) | ||||
| 14 | Aceclofenac (SR) and Thiocolchicoside (SR) Capsules | Each Hard Gelatin Capsule Contains : Aceclofenac IP 200 mg (As Sustained Release Pellets) & Thiocolchicoside IP 8 mg (As Sustained Release Pellets) | ||||
| 15 | Itraconazole Capsules | Each Hard Gelatin Capsule Contains : Itraconazole Pellets Eq. to Itraconazole BP 100 mg. | ||||
| 16 | Itraconazole Capsules | Each Hard Gelatin Capsule Contains : Itraconazole Pellets Eq. to Itraconazole BP 200 mg. | ||||
| 17 | Rabeprazole Sodium (Enteric Coated) and Domperidone (Sustained Release) Capsules | Each Hard Gelatin Capsule Contains : Rabeprazole Sodium IP 20 mg(As Enteric Coated Pellets)& Domperidone IP 30 mg(As Sustained Release Pellets) | ||||
| 18 | Frusemide & Spironolactone Capsules | Each Hard Gelatin Capsule Contains : Frusemide IP 20 mg & Spironolactone IP 100 mg. | ||||
| 19 | Pantoprazole (Enteric Coated) & Domperidone (Sustained Release) Capsules | Each Hard Gelatin Capsule Contains : Pantoprazole Sodium Sesquihydrate IP Eq. to Pantoprazole 40 mg(As Enteric Coated Pellets)& Domperidone IP 30 mg(As Sustained Release Pellets) | ||||
| 20 | Pantoprazole (Enteric Coated) & Itopride Hydrochloride (Sustained Release) Capsules | Each Hard Gelatin Capsule Contains : Pantoprazole Sodium Sesquihydrate IP Eq. to Pantoprazole 40 mg(As Enteric Coated Pellets)&Itopride Hydrochloride IP 150 mg(As Sustained Release Pellets) | ||||
| 21 | Pantoprazole (Enteric Coated) & Levosulpiride (Sustained Release) Capsules | Each Hard Gelatin Capsule Contains : Pantoprazole Sodium Sesquihydrate IP Eq. to Pantoprazole 40 mg(As Enteric Coated Pellets)& Levosulpiride IP 75 mg(As Sustained Release Pellets) | ||||
| 22 | Omeprazole Capsules IP | Each Hard Gelatin Capsule Contains : Omeprazole IP 20 mg (As Enteric Coated Pellets) | ||||
| 23 | Omeprazole & Domperidon Capsules IP | Each Hard Gelatin Capsule Contains : Omeprazole IP 20 mg (As Enteric Coated Pellets)& Domperidone IP 10 mg. | ||||
| CAPSULES BETA LACTAM | ||||||
| S.No | PRODUCT NAME | COMPOSITION | ||||
| 1 | Amoxycillin & Dicloxacillin Capsules | Each Hard Gelatin Capsule Contains : Amoxycillin Trihydrate IP Eq. to Amoxycillin 250 mg & Dicloxacillin Sodium IP Eq. to Dicloxacillin 250 mg. Excipients q.s. | ||||
| 2 | Amoxycillin & Lactobacillus Capsules | Each Hard Gelatin Capsule Contains : Amoxycillin Trihydrate IP Eq. to Amoxycillin 500 mg & Lactobacillus 1.66 Billion Spores. Excipients q.s. | ||||
| 3 | Amoxycillin Capsules IP | Each Hard Gelatin Capsule Contains : Amoxycillin Trihydrate IP Eq. to Amoxycillin 250 mg. Excipients q.s. | ||||
| 4 | Amoxycillin Capsules IP | Each Hard Gelatin Capsule Contains : Amoxycillin Trihydrate IP Eq. to Amoxycillin 500 mg. Excipients q.s. | ||||
| 5 | Cefadroxil Capsules IP | Each Hard Gelatin Capsule Contains : Cefadroxil Monohydrate IP Eq. to Cefadroxil Anhydrous 500 mg. Excipients q.s. | ||||
| 6 | Ampicillin Capsules IP | Each Hard Gelatin Capsule Contains : Ampicillin Trihydrate IP Eq. to Ampicillin 250 mg. Excipients q.s. | ||||
| 7 | Cephalexin Capsules IP | Each Hard Gelatin Capsule Contains : Cephalexin IP Eq. to Anhydrous Cephalexin 250 mg. | ||||
| 8 | Cephalexin Capsules IP | Each Hard Gelatin Capsule Contains : Cephalexin IP Eq. to Anhydrous Cephalexin 500 mg. | ||||
| 9 | Cephalexin & Bromhexine Hydrochloride Capsules | Each Hard Gelatin Capsule Contains : Cephalexin IP Eq. to Anhydrous Cephalexin 500 mg & Bromhexine Hydrochloride IP 8 mg. | ||||
| 10 | Cephalexin & Bromhexine Hydrochloride Capsules | Each Hard Gelatin Capsule Contains : Cephalexin IP Eq. to Anhydrous Cephalexin 250 mg & Bromhexine Hydrochloride IP 4 mg. | ||||
| 11 | Cephalexin & Carbosisteine Capsules | Each Hard Gelatin Capsule Contains : Cephalexin IP Eq. to Anhydrous Cephalexin 500 mg & Carbosisteine IP 150 mg. | ||||
| 12 | Cephalexin & Carbosisteine Capsules | Each Hard Gelatin Capsule Contains : Cephalexin IP Eq. to Anhydrous Cephalexin 250 mg & Carbosisteine IP 150 mg. | ||||
| DRY SYRUP BETA LACTAM | ||||||
| S.NO | PRODUCT NAME | COMPOSITION | ||||
| 1 | AmoxyClav Dry Syrup (Single Strength) | Amoxycillin 200 + Clavulanic Acid 28.5 MG (Dry Syrup) | ||||
| 2 | AmoxyClav Dry Syrup (Double Strength) | Amoxycillin400 + Clavulanic Acid 57 mg (Dry Syrup) | ||||
| 3 | Cefpodoxime Proxetil Oral Suspension IP | Each 5 ml. of the Reconstituted Suspension Contains : Cefpodoxime Proxetil IP Eq. to Cefpodoxime 50 mg. Excipients q.s. | ||||
| 4 | Cefpodoxime Proxetil Oral Suspension IP | Each 5 ml. of the Reconstituted Suspension Contains : Cefpodoxime Proxetil IP Eq. to Cefpodoxime 100 mg. Excipients q.s. | ||||
| 5 | Cefpodoxime & clav | Cefpodoxime 50 + Clavulanic acid 31.25 mg | ||||
| 6 | Cefixime Oral Suspension IP | Each 5 ml. of the Reconstituted Suspension Contains : Cefixime (As Trihydrate) IP Eq. to Cefixime (Anhydrous) 50 mg. | ||||
| 7 | Cefixime Oral Suspension IP | Each 5 ml. of the Reconstituted Suspension Contains : Cefixime (As Trihydrate) IP Eq. to Cefixime (Anhydrous) 100 mg. Excipients q.s. | ||||
| 8 | Cefixime Oral Suspension IP | Each 5 ml. of the Reconstituted Suspension Contains : Cefixime (As Trihydrate) IP Eq. to Cefixime (Anhydrous) 200 mg. Excipients q.s. | ||||
| 9 | Cefixime Clav Dry Syrup | Cefixime 50 + Clavulanic Acid 31.25 mg (Dry Syrup) | ||||
| ORAL LIQUIDS | ||||||
| S.NO | PRODUCT NAME | COMPOSITION | ||||
| 1 | Salbutamol Sulphate Syrup IP | Each 5 ml Contains : Salbutamol Sulphate IP Eq. to Salbutamol 2 mg | ||||
| 2 | Levosalbutamol Syrup IP | Each 5 ml Contains : Levosalbutamol Sulphate IP Eq. to Levosalbutamol 1 mg | ||||
| 3 | Levofloxacin Oral Suspension IP | Each 5 ml Contains : Levofloxacin IP 125 mg. | ||||
| 4 | Promethazine Hydrochloride Syrup IP | Each 5 ml Contains : Promethazine Hydrochloride IP 5 mg. | ||||
| 5 | Fungal Distage & Pepsin Syrup | Each 5 ml Contains : Fungal (1: 1200) IP 50 mg(Fungal Distage derived from Aspergillus oryzae . Digest not less than 60 g of cooked starch)& Pepsin (1:3000) IP 10 mg(Digest not less than 30 g of coagulated egg albumin) | ||||
| 6 | Sodium Picosulfate Oral Solution B.P. | Each 5 ml Contains : Sodium Picosulfate BP 5 mg. | ||||
| 7 | Cholecalciferol (Vitamin D3) Drop | Each ml Contains : Cholecalciferol IP 800 I.U.(Vitamin D3) | ||||
| 8 | Cholecalciferol (Vitamin D3) Drop | Each 5 ml Contains : Cholecalciferol IP 60000 I.U.(Vitamin D3) | ||||
| 9 | Di-Sodium Hydrogen Citrate Solution | Each ml Contains : Di-Sodium Hydrogen Citrate BP 1.38 gm. | ||||
| 10 | Megaldrate Simethicone & Oxetacaine Suspension | Each 5 ml Contains :Megaldrate IP 480 mg & Simethicone IP 50 mg & Oxetacaine BP 10 mg. | ||||
| 11 | Sucralfate & Oxetacaine Suspension | Each 10 ml Contains : Sucralfate IP 1 g & Oxetacaine BP 20 mg. | ||||
| 12 | Cyproheptadine Hydrochloride & Tricholine | Each 5 ml Contains : Cyproheptadine Hydrochloride IP (Anhydrous) 2 mg & Tricholine Citrate 275 mg. | ||||
| 13 | Zinc Gluconate Solution | Each 5 ml Contains : Zinc Gluconate Solution 20mg. | ||||
| 14 | Mefenamic Acid & Paracetamol Suspension | Each 5 ml Contains : Mefenamic Acid IP 100 mg & Paracetamol IP 250 mg. | ||||
| 15 | Dextrometharpahan Hydrobromide, Phenylephrine Hydrochloride & Chlorpheniramine Maleate Syrup | Each 5 ml Contains : Dextrometharpahan Hydrobromide IP 10 mg & Phenylephrine Hydrochloride IP 5 mg & Chlorpheniramine Maleate IP 2 mg. | ||||
| 16 | Azithromycin Oral Suspension IP | Each 5 ml Contains : Azithromycin (Dihydrate) IP Eq. to Azithromycin (Anhydrous) 100 mg. | ||||
| 17 | Cetirizine Dihydrochloride & Ambroxol Hydrochloride Syrup | Each 5 ml Contains : Cetirizine Dihydrochloride IP 10 mg & Ambroxol Hydrochloride IP 30 mg. | ||||
| 18 | Citicoline & Piracetam Syrup | Each 5 ml Contains : Citicoline IP 500 mg & Piracetam IP 400 mg. | ||||
| 19 | Levocetirizine Dihydrochloride & Ambroxol Hydrochloride Syrup | Each 5 ml Contains : Levocetirizine Dihydrochloride IP 2.5 mg & Ambroxol Hydrochloride IP 30 mg. | ||||
| 20 | Levocetirizine Dihydrochloride & Ambroxol Hydrochloride Syrup | Each 5 ml Contains : Levocetirizine Dihydrochloride IP 5 mg & Ambroxol Hydrochloride IP 30 mg. | ||||
| 21 | Dextrometharpahan Hydrobromide & Chlorpheniramine Maleate Syrup | Each 5 ml Contains : Dextrometharpahan Hydrobromide 10 mg & Chlorpheniramine Maleate IP 2 mg. | ||||
| 22 | Dicyclomine Dried Aluminium Hydroxide, Light Magnesium Oxide & Simethicone Suspension | Each 5 ml Contains : Dicyclomine IP 2.5 mg & Dried Aluminium Hydroxide IP 200 mg & Light Magnesium Oxide IP 100 mg & Simethicone Suspension IP 20 mg. (In a flavoured sorbitol base) | ||||
| 23 | Albendazole Suspension IP | Each 5 ml Contains : Albendazole IP 200 mg. | ||||
| 24 | Paracetamol, Phenylephrine Hydrochloride & Chlorpheneramine Maleate, Sodium Citrate & Menthol Syrup | Each 5 ml Contains : Paracetamol IP 125 mg & Phenylephrine Hydrochloride IP 5 mg & Chlorpheneramine Maleate IP 0.5 mg& Sodium Citrate IP 60 mg & Menthol IP 1 mg. | ||||
| 25 | Dried Aluminium Hydroxide Gel, Magnesium Hydroxide, Simethicone & Oxetacaine Suspension | Each 5 ml Contains : Dried Aluminium Hydroxide Gel IP 600 mg & Magnesium Hydroxide IP 300 mg & Simethicone IP 25 mg & Oxetacaine BP 10 mg. (In a flavoured sorbitol base) | ||||
| 26 | Ambroxol Hydrochloride, Guiphenesin, Terbutaline Sulphate & Menthol Syrup | Each 5 ml Contains : Ambroxol Hydrochloride IP 15 mg & Guiphenesin IP 50 mg & Terbutaline Sulphate IP 1.25 mg & Menthol IP 2.5 mg. | ||||
| 27 | Ambroxol Hydrochloride, Guiphenesin, Terbutaline Sulphate & Menthol Syrup | Each 5 ml Contains : Ambroxol Hydrochloride IP 30 mg & Guiphenesin IP 100 mg & Terbutaline Sulphate IP 2.5 mg & Menthol IP 2.5 mg. | ||||
| 28 | Levosalbutamol Sulphate, Ambroxol Hydrochloride, Guiphenesin Syrup | Each 5 ml Contains : Levosalbutamol Sulphate IP & Eq. to Levosalbutamol 1 mg & Ambroxol Hydrochloride IP 30 mg & Guiphenesin IP 50 mg. | ||||
| 29 | Megaldrate & Simethicone Oral Suspension | Each 5 ml Contains : Megaldrate IP 480 mg & Simethicone IP 60 mg.(In a flavoured sorbitol base) | ||||
| 30 | Ambroxol HCL, Salbutamol Sulphate, Guiphenesin & Menthol Syrup | Each 5 ml Contains : Ambroxol HCL. IP 15 mg & Salbutamol Sulphate IP Eq. to Salbutamol 1 mg& Guiphenesin IP 50 mg & Menthol IP 1 mg. | ||||
| ORAL LIQUIDS GENERAL | ||||||
| S.NO | PRODUCT NAME | COMPOSITION | ||||
| 1 | Azithromycin Oral Suspension IP | Each 5 ml. Contains : Azithromycin (Dihydrate) IP Eq. to Azithromycin (Anhydrous) 100 mg. | ||||
| 2 | Azithromycin Oral Suspension IP | Each 5 ml. Contains : Azithromycin (Dihydrate) IP Eq. to Azithromycin (Anhydrous) 200 mg. | ||||
| 3 | Ofloxacin Oral Suspension IP | Each 5 ml. Contains : Ofloxacin IP 50 mg. | ||||
| 4 | Ofloxacin Oral Suspension IP | Each 5 ml. Contains : Ofloxacin IP 100 mg. | ||||
| 5 | Ondansetron Oral Solution IP | Each 5 ml. Contains : Ondansetron Hydrochloride (Dihydrate) IP Eq. to Ondansetron 2 mg. | ||||
| 6 | Paracetamol Oral Suspension IP | Each 5 ml. Contains : Paracetamol IP 250 mg. | ||||
| 7 | Levocetrizine Dihydrochloride, Montelukast Sodium Syrup | Each 5 ml. Contains : Levocetrizine Dihydrochloride IP 2.5 mg & Montelukast Sodium IP 5 mg. | ||||
| 8 | Levocetrizine Dihydrochloride, Montelukast Sodium Syrup | Each 5 ml. Contains : Levocetrizine Dihydrochloride IP 5 mg & Montelukast Sodium IP 10 mg. | ||||
| 9 | Ferrous Ascorbate & Folic Acid Suspension | Each 5 ml. Contains : Ferrous Ascorbate Eq. to Elemental Iron 30 mg & Folic Acid IP 550 mcg. | ||||
| NEUTRACEUTICAL POWDER | ||||||
| S.NO | PRODUCT NAME | COMPOSITION | ||||
| 1 | Galpha | |||||
| 2 | Dha | |||||
| 3 | Gempro | |||||
| 4 | Lycopene | |||||
| 5 | Dha + Gla | |||||
| 6 | Whey DHA | |||||
| SACHETS | ||||||
| S.NO | PRODUCT NAME | COMPOSITION | ||||
| 1 | Ors Sachet 21.8 gm | Oral Rehydration Salt IP 21.8 gm | ||||
| 2 | Cholecalciferol sachet 1gm | Cholecalciferol Granules Sachet 1 gm | ||||
| ENERGY DRINK | ||||||
| S.NO | PRODUCT NAME | COMPOSITION | ||||
| 1 | Energy drink | Energy drink 105gm |
Contact For third party manufacturing:-
Website:- https://doyo.co.in/
E-mail i’d :- Doyoseo@gmaiol.com
Contact No:- 9814135709
DOYO 